Pharming (PHAR) Long-Term Investments (2019 - 2025)

Pharming's Long-Term Investments history spans 7 years, with the latest figure at $1.9 million for Q4 2025.

  • Quarterly results put Long-Term Investments at $1.9 million for Q4 2025, up 317.17% from a year ago — trailing twelve months through Dec 2025 was $1.9 million (up 317.17% YoY), and the annual figure for FY2025 was $1.9 million, up 317.17%.
  • Long-Term Investments for Q4 2025 was $1.9 million at Pharming, up from $466000.0 in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $2.5 million in Q4 2022 to a low of $466000.0 in Q4 2024.
  • The 5-year median for Long-Term Investments is $1.9 million (2025), against an average of $1.7 million.
  • The sharpest move saw Long-Term Investments plummeted 79.61% in 2024, then surged 317.17% in 2025.
  • Year by year, Long-Term Investments stood at $1.4 million in 2021, then skyrocketed by 72.6% to $2.5 million in 2022, then decreased by 8.64% to $2.3 million in 2023, then plummeted by 79.61% to $466000.0 in 2024, then surged by 317.17% to $1.9 million in 2025.
  • According to Business Quant data, Long-Term Investments over the past three periods came in at $1.9 million, $466000.0, and $2.3 million for Q4 2025, Q4 2024, and Q4 2023 respectively.